Clinical trial
Prophylactic Effects of Different Duration of Intravenous Ampicillin for Preventing Surgical Site Infection in Third Molar Surgery: a Randomized Controlled Trial
NCT06368102 is registered in ClinicalTrials.gov with Uji Takeda Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Effects of Different Duration of Intravenous Ampicillin for Preventing Surgical Site Infection in Third Molar Surgery: a Randomized Controlled Trial
- Lead sponsor
- Uji Takeda Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 2, 2024
- Completion date
- September 1, 2025
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
surgical site infection